This is an exciting opportunity to be a part of a large project to deploy MES at site and integration of DeltaV with cell and gene therapy unit operations as we progress from clinical to commercial operations. Learn more:  #DaretoBeam #GMPManufacturing.

We’re looking for a passionate and experienced Automation Engineer with experience in DeltaV and using an MES Platform to join the North Carolina #BeamTeam to help shape the future of genetic medicine.

The #BeamTeam had a great time celebrating #Pride this month by hosting tie dye events in Cambridge and North Carolina, walking in the Boston Pride Parade, and participating in the OUT! Raleigh Pride Festival. We’re proud to be powered by difference. #DaretoBeam

We're happy to share that the Beam Summer Blast was, in fact, a blast! The Cambridge #BeamTeam, along with family & friends, came together at the @museumofscience. What a way to kick off summer and celebrate our 8-year anniversary as a company! #DaretoBeam

- World Sickle Cell Disease Day Event hosted by Sickle Cell Association of Houston.- World Sickle Cell Day Juneteenth Jubilee Health Fair & Blood Drive hosted by @AsOneFoundation.

- 2025 Red Ribbon Gala hosted by @MSCAssoc .- Cure Sickle Cell Walk hosted by Children’s Hospital of Philadelphia.- Scholarship & Awards Luncheon hosted by Advancing Sickle Cell Advocacy Project.- Annual World Sickle Cell Day Marathon hosted by @CayenneWellness & @globalscdorgs.

Today is World Sickle Cell Day, a day observed annually to raise awareness and increase public knowledge around #sicklecelldisease. Throughout the month the #BeamTeam has attended and sponsored many great events hosted by the organizations below:

The #BeamTeam is growing! We're hiring across many functions at our Cambridge and North Carolina locations. Check out our open roles and #DaretoBeam:

Read the full press release here: #DaretoBeam #BeamTeam #EHA2025.

Additionally, Beam will host a conference call & webcast today, at 4:00 p.m. ET to review the BEACON-101 data & other key presentations from this year’s EHA meeting. A live webcast of the presentation will be available under "Events" in the Investors section of the website.

Beam announced new safety & efficacy data from its BEACON Phase 1/2 clinical trial of BEAM-101 in patients with sickle cell disease with severe vaso-occlusive crises, which will be shared this afternoon in a poster presentation at the EHA2025 Congress.

We’re thrilled to welcome our newest class of interns to the #BeamTeam! We’re excited to see the impact you’ll make and can’t wait to see how you #DaretoBeam this summer.

As our co-ops wrap up their time with us, they shared their capstone presentations with the #BeamTeam to showcase their innovative work. Thank you all for your contributions and fresh perspectives, and we look forward to seeing your continued accomplishments! #DaretoBeam

Today, we announced that the US FDA has granted orphan drug designation to BEAM-101, an investigational genetically modified cell therapy for the treatment of sickle cell disease (SCD). Read the full press release here: #DaretoBeam #BeamTeam

Today, we announced that the United States Food and Drug Administration has granted orphan drug designation to BEAM-302. Read the full press release here: #DaretoBeam #BeamTeam

At our annual internal R&D Symposium, members of the #BeamTeam presented on their current work. It’s a great opportunity to foster continued collaboration, further develop presenting skills, and hear a variety of perspectives to challenge the way we think. #DaretoBeam

Additionally, Beam will host an investor webcast on Friday, June 13th at 4 pm ET to go over key presentations from this year’s EHA meeting. Read the full press release here: #DaretoBeam #BeamTeam.

Beam will present new data from the BEACON Phase 1/2 clinical trial of BEAM-101 in sickle cell disease (SCD) at the European Hematology Association 2025 Congress (EHA2025), taking place June 12-15, 2025, in Milan, Italy.

The live webcast will be available in the investor section of Beam’s website. More on this conference here: #BeamTeam.

Today, we announced that management will participate in a fireside chat at the 2025 RBC Capital Markets Global Healthcare Conference on Tuesday, May 20, 2025, at 11:00 a.m. ET.